Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study

Italy has been the first Western country to be heavily affected by the spread of SARS-COV-2 infection and among the pioneers of the clinical management of pandemic. To improve the outcome, identification of patients at the highest risk seems mandatory. Aim of this study is to identify comorbidities...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 15; no. 12; p. e0243700
Main Authors Galiero, Raffaele, Pafundi, Pia Clara, Simeon, Vittorio, Rinaldi, Luca, Perrella, Alessandro, Vetrano, Erica, Caturano, Alfredo, Alfano, Maria, Beccia, Domenico, Nevola, Riccardo, Marfella, Raffaele, Sardu, Celestino, Coppola, Carmine, Scarano, Ferdinando, Maggi, Paolo, De Lucia Sposito, Pellegrino, Vocciante, Laura, Rescigno, Carolina, Sbreglia, Costanza, Fraganza, Fiorentino, Parrella, Roberto, Romano, Annamaria, Calabria, Giosuele, Polverino, Benedetto, Pagano, Antonio, Bologna, Carolina, Amitrano, Maria, Esposito, Vincenzo, Coppola, Nicola, Maturo, Nicola, Adinolfi, Luigi Elio, Chiodini, Paolo, Sasso, Ferdinando Carlo
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 10.12.2020
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Italy has been the first Western country to be heavily affected by the spread of SARS-COV-2 infection and among the pioneers of the clinical management of pandemic. To improve the outcome, identification of patients at the highest risk seems mandatory. Aim of this study is to identify comorbidities and clinical conditions upon admission associated with in-hospital mortality in several COVID Centers in Campania Region (Italy). COVOCA is a multicentre retrospective observational cohort study, which involved 18 COVID Centers throughout Campania Region, Italy. Data were collected from patients who completed their hospitalization between March-June 2020. The endpoint was in-hospital mortality, assessed either from data at discharge or death certificate, whilst all exposure variables were collected at hospital admission. Among 618 COVID-19 hospitalized patients included in the study, 143 in-hospital mortality events were recorded, with a cumulative incidence of about 23%. At multivariable logistic analysis, male sex (OR 2.63, 95%CI 1.42-4.90; p = 0.001), Chronic Liver Disease (OR 5.88, 95%CI 2.39-14.46; p<0.001) and malignancies (OR 2.62, 95%CI 1.21-5.68; p = 0.015) disclosed an independent association with a poor prognosis, Glasgow Coma Scale (GCS) and Respiratory Severity Scale allowed to identify at higher mortality risk. Sensitivity analysis further enhanced these findings. Mortality of patients hospitalized for COVID-19 appears strongly affected by both clinical conditions on admission and comorbidities. Originally, we observed a very poor outcome in subjects with a chronic liver disease, alongside with an increase of hepatic damage.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
Membership of the COVOCA Study Group is provided in the Acknowledgments.
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0243700